The REDDIE consortium comprises 14 partners from 8 European countries and includes the full expertise needed to understand assessing real world data to complement trial data within diabetes-related research to improve health outcomes, including state-of-the-art analyses such as machine learning and synthetic data creation.
Project Partners
Austria
Denmark
- Danish Medicines Agency (DMA) – København, Denmark
- Region Hovedstaden (NOH)– Hillerød, Denmark
- Novo Nordisk A/S (Novo Nordisk) – Bagsværd, Denmark
Germany
- Eurice – European Research and Project Office GmbH (EURICE) – St.Ingbert, Germany
- Universitaet Ulm (UULM) – Ulm, Germany
Italy
Netherlands
- Stichting Radboud Universitair Medisch Centrum (RADBOUD) – Nijmegen, Netherlands
Sweden
United Kingdom
- Imperial College of Science Technology and Medicine (Imperial) – London, UK
- The University of Manchester (UNIMAN) – Manchester, UK
- University of Leicester (ULEIC) – Leicester, UK
- The Chancellor, Masters and Scholars of the University of Oxford (UOXF) – Oxford, UK
- The University of Warwick (Warwick) – Coventry, UK